SLC5A2 and myocardial infarction: n = number of patients needed to be treated (up to the follow-up duration of the respective study); T = number of patient-years of treatment required per event prevention; ICER = incremental cost-effectiveness ratio; SGLT-2 = sodium-glucose cotransporter-2; ACD = all-cause death; HHF = hospitalization for heart failure; MI = myocardial infarction; 3P-MACE = three-point major adverse cardiac event.